Metastatic pancreatic cancer
Clinical trials for Metastatic pancreatic cancer explained in plain language.
Never miss a new study
Get alerted when new Metastatic pancreatic cancer trials appear
Sign up with your email to follow new studies for Metastatic pancreatic cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a smart drug outsmart pancreatic cancer?
Disease control Not yet recruitingThis phase III trial tests an experimental drug called YL201 against standard chemotherapy in people with metastatic pancreatic cancer that has progressed after gemcitabine-based treatment. YL201 is designed to deliver a toxin directly to cancer cells that carry a specific marker…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase 3 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a Triple-Drug combo outsmart pancreatic cancer?
Disease control Not yet recruitingThis trial tests whether adding an experimental immunotherapy (SHR-1701) and a targeted drug (apatinib) to standard chemotherapy (gemcitabine and nab-paclitaxel) can help people with advanced pancreatic cancer. The study enrolls adults aged 18 to 75 who have not yet received trea…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase 1/2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Smart drug delivers chemo directly to pancreatic cancer cells
Disease control Not yet recruitingThis early-phase trial tests an experimental drug called XNW28012 in people with metastatic pancreatic cancer whose disease has worsened after at least one prior treatment. XNW28012 is an antibody-drug conjugate designed to seek out a protein called tissue factor on cancer cells …
Matched conditions: METASTATIC PANCREATIC CANCER
Phase 1 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New personalized vaccine takes on tough cancers
Disease control Not yet recruitingThis early-stage trial tests a personalized cancer vaccine called ODI-2001 in 77 people with advanced colon or pancreatic cancer that has spread or cannot be removed. The vaccine is custom-made for each patient's tumor and is given along with a drug that boosts the immune system.…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase 1 • Sponsor: Centre Georges Francois Leclerc • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Triple threat: radiation and immunotherapy join chemo against pancreatic cancer
Disease control Not yet recruitingThis Phase III trial tests whether adding targeted radiation and an immunotherapy drug (serplulimab) to standard chemotherapy can help people with advanced pancreatic cancer live longer. About 198 participants who have not had prior treatment will be randomly assigned to receive …
Matched conditions: METASTATIC PANCREATIC CANCER
Phase 3 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Experimental vaccine takes on tough pancreatic cancer
Disease control Not yet recruitingThis early-phase trial will test a new tumor vaccine (SapDM275) combined with standard chemotherapy in 13 people with metastatic pancreatic cancer who have not had prior treatment. The vaccine aims to help the immune system attack cancer cells. The main goal is to check safety, b…
Matched conditions: METASTATIC PANCREATIC CANCER
Early phase 1 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC